Green - I read that to mean they need to trial it from a sales/marketing perspective, not regulatory. They need to prove it works before anyone will buy it. Of course that doesn't exactly jive with what they have been claiming for years - that they have hospitals that are desparate to buy it, but are just waiting for approval. So the saga continues ...
"WHY.............WHY............must they enter into a Brief Trial/Demonstration period to confirm replication of results?"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.